Dramatic Response to Pemetrexed in a Patient with Pneumonic-Type Mucinous Bronchioloalveolar Carcinoma David H. Garfield, MD, Wilbur Franklin, MD Journal of Thoracic Oncology Volume 6, Issue 2, Pages 397-398 (February 2011) DOI: 10.1097/JTO.0b013e3182011f59 Copyright © 2011 International Association for the Study of Lung Cancer Terms and Conditions
FIGURE 1 A, PA chest x-ray at presentation. B, CT chest after 1 month of antibiotics, showing right lung infiltrate (arrow) and mass (X). C, PA after 6 months of pemetrexed. D, CT chest after 6 months of pemetrexed, showing the infiltrate almost gone, mass much smaller (arrow). PA, •••; CT, computed tomography. Journal of Thoracic Oncology 2011 6, 397-398DOI: (10.1097/JTO.0b013e3182011f59) Copyright © 2011 International Association for the Study of Lung Cancer Terms and Conditions
FIGURE 2 A, Low-power view at time of diagnosis. B, Ki-67 staining 4+. C, Folate receptor alpha membrane staining 3+. D, Thymidylate synthase nuclear staining 1 to 2+. Journal of Thoracic Oncology 2011 6, 397-398DOI: (10.1097/JTO.0b013e3182011f59) Copyright © 2011 International Association for the Study of Lung Cancer Terms and Conditions